Bone Marrow Transplantation - Table of Contents alert Volume 53 Issue n5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 53, Issue 5 In this issue Editorial Review Article Article Correspondence Also new AOP   Editorial Introducing Prof. Shaun McCann, Bone Marrow Transplantation’s New Sommelier Robert Peter Gale Bone Marrow Transplantation 2018 53 :519 - 520; May 04, 2018; 10.1038/s41409-018-0129-1   Abstract | Full Text Review Article The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation Stefan O. Ciurea, Kai Cao, Marcelo Fernadez-Vina, Piyanuch Kongtim, Monzr Al Malki et al. Bone Marrow Transplantation 2018 53 :521 - 534; January 15, 2018; 10.1038/s41409-017-0062-8   Abstract | Full Text Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT David Buchbinder, Debra Lynch Kelly, Rafael F. Duarte, Jeffery J. Auletta, Neel Bhatt et al. Bone Marrow Transplantation 2018 53 :535 - 555; January 17, 2018; 10.1038/s41409-017-0055-7   Abstract | Full Text Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review Mohamad Baydoun & Debra L. Barton Bone Marrow Transplantation 2018 53 :556 - 564; January 16, 2018; 10.1038/s41409-017-0073-5   Abstract | Full Text Article Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis Barbara Deschler, Gabriele Ihorst, Susanne Schnitzler, Hartmut Bertz & Juergen Finke Bone Marrow Transplantation 2018 53 :565 - 575; January 12, 2018; 10.1038/s41409-017-0021-4   Abstract | Full Text Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients Melhem M. Solh, Asad Bashey, Scott R. Solomon, Lawrence E. Morris, Xu Zhang et al. Bone Marrow Transplantation 2018 53 :576 - 583; January 15, 2018; 10.1038/s41409-017-0076-2   Abstract | Full Text A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation Helge Schumacher, Sabrina Stüwe, Peter Kropp, Doreen Diedrich, Sebastian Freitag et al. Bone Marrow Transplantation 2018 53 :584 - 590; January 15, 2018; 10.1038/s41409-017-0070-8   Abstract | Full Text Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma Massimo Eraldo Abate, Anna Paioli, Sivlia Cammelli, Marilena Cesari, Alessandra Longhi et al. Bone Marrow Transplantation 2018 53 :591 - 599; January 15, 2018; 10.1038/s41409-017-0066-4   Abstract | Full Text Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation Ming-Rui Huo, Xu-Ying Pei, Dan Li, Ying-Jun Chang, Lan-Ping Xu et al. Bone Marrow Transplantation 2018 53 :600 - 608; January 15, 2018; 10.1038/s41409-017-0072-6   Abstract | Full Text The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis Hidehiko Saito, Masaharu Ito, Shunichi Kato, Yoshihisa Kodera, Shinichiro Okamoto et al. Bone Marrow Transplantation 2018 53 :609 - 616; January 24, 2018; 10.1038/s41409-017-0084-2   Abstract | Full Text Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party Stephen P. Robinson, Ariane Boumendil, Herve Finel, Karl S. Peggs, Patrice Chevallier et al. Bone Marrow Transplantation 2018 53 :617 - 624; January 15, 2018; 10.1038/s41409-017-0067-3   Abstract | Full Text Full-body physical therapy evaluation for pre- and post-hematopoietic cell transplant patients and the need for a modified rehabilitation musculoskeletal specific grading system for chronic graft-versus-host disease Jaleel Mohammed, Ahmed AlGhamdi & Shahrukh K. Hashmi Bone Marrow Transplantation 2018 53 :625 - 627; January 18, 2018; 10.1038/s41409-017-0075-3   Abstract | Full Text Correspondence Topical vitamin D analog for chronic graft versus host disease of the skin Gregory Wallace, Kasiani C. Myers, Ashley Teusink-Cross, Stella M. Davies, Pooja Khandelwal et al. Bone Marrow Transplantation 2018 53 :628 - 633; January 15, 2018; 10.1038/s41409-017-0031-2   Abstract | Full Text Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources Takafumi Shichijo, Shigeo Fuji, Kinuko Tajima, Hiroyuki Kubo, Kenji Nozaki et al. Bone Marrow Transplantation 2018 53 :634 - 639; January 15, 2018; 10.1038/s41409-017-0045-9   Abstract | Full Text Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation Laura K. Schmalbrock, Lynn Bonifacio, Marius Bill, Madlen Jentzsch, Karoline Schubert et al. Bone Marrow Transplantation 2018 53 :640 - 643; January 15, 2018; 10.1038/s41409-017-0060-x   Abstract | Full Text Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease Elisabetta Calore, Antonio Marzollo, Mara Cananzi, Marco Pizzi, Massimo Rugge et al. Bone Marrow Transplantation 2018 53 :644 - 646; January 15, 2018; 10.1038/s41409-017-0065-5   Abstract | Full Text Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide Haydar Frangoul, Misty Evans, Julie Isbell, Katie Bruce & Jennifer Domm Bone Marrow Transplantation 2018 53 :647 - 650; January 16, 2018; 10.1038/s41409-017-0077-1   Abstract | Full Text BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia Amro Elshoury, Paul K. Wallace, Michael J. Borowitz, Angela Kader, Chris Choi et al. Bone Marrow Transplantation 2018 53 :651 - 653; January 17, 2018; 10.1038/s41409-017-0036-x   Abstract | Full Text Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma Oscar B. Lahoud, Alison J. Moskowitz, Steven M. Horwitz, Sergio A. Giralt & Parastoo B. Dahi Bone Marrow Transplantation 2018 53 :654 - 656; January 22, 2018; 10.1038/s41409-017-0086-0   Abstract | Full Text Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand et al. Bone Marrow Transplantation 2018 53 :657 - 660; January 22, 2018; 10.1038/s41409-018-0091-y   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.